Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

97.09
BATS BZX Real-Time Price
As of 11:27am ET
 +2.24 / +2.36%
Today’s Change
92.98
Today|||52-Week Range
140.72
-18.93%
Year-to-Date
Forget Stem Cell Stocks: Here Are 3 Clinical-Stage Biotechs to Buy Instead
9:46am / MotleyFool.com - Paid Partner Content
Biotech Stocks Rally on Medicare Cost-Cutting Stand Down
Jun 22 / TheStreet.com - Paid Partner Content
When Will Gilead Sciences, Celgene, and CVS Health Hit $100 Again?
Jun 27 / MotleyFool.com - Paid Partner Content
Celgene: Is It a Buy?
Jun 21 / GuruFocus News - Paid Partner Content
How Does Brexit Impact Healthcare Stocks?
Jun 27 / Zacks.com - Paid Partner Content
These 5 Biotech Stocks Are Ridiculously Cheap
Jun 21 / MotleyFool.com - Paid Partner Content
Better Buy: Bellicum Pharmaceuticals, Inc. vs. Juno Therapeutics, Inc.
Jun 26 / MotleyFool.com - Paid Partner Content
The Single Best Stock to Own Today
Jun 20 / MotleyFool.com - Paid Partner Content
The 5 Best Healthcare ETFs
Jun 26 / MotleyFool.com - Paid Partner Content
Better Buy: Ziopharm Oncology, Inc. vs. Celgene
Jun 18 / MotleyFool.com - Paid Partner Content
3 Biotech Stocks to Buy Now for the Long Haul
Jun 25 / MotleyFool.com - Paid Partner Content
3 Top Stocks We're Excited About
Jun 18 / MotleyFool.com - Paid Partner Content
2 Biotech Stocks That Won't Pay a Dividend Anytime Soon, and 1 That Should
Jun 24 / MotleyFool.com - Paid Partner Content
Digging Below the Surface: Here's What Celgene's New Stock Buyback Really Implies
Jun 17 / MotleyFool.com - Paid Partner Content
RBC sees biopharma 'insulated' from Brexit, says buy Celgene for bounceback
Jun 24 / TheStreet.com - Paid Partner Content
Company News for June 16, 2016
Jun 16 / Zacks.com - Paid Partner Content
Why Investors Are Paying a Premium for These 3 Drugmakers
Jun 24 / MotleyFool.com - Paid Partner Content
3 Simple Ways for People in Their 50s and 60s to Make Money in a Low-Interest-Rate En...
Jun 16 / MotleyFool.com - Paid Partner Content
Better Buy: Biogen Inc. vs. Celgene Corporation
Jun 23 / MotleyFool.com - Paid Partner Content
3 Stocks to Own for the Next Decade
Jun 15 / MotleyFool.com - Paid Partner Content
Prima Reports Favorable Initial Breast Cancer Study Data
Jun 22 / Zacks.com - Paid Partner Content
Better Buy: Johnson & Johnson vs. Eli Lilly
Jun 15 / MotleyFool.com - Paid Partner Content
Worst Is Yet to Come for Celgene?
Jun 22 / TheStreet.com - Paid Partner Content
3 Biotech Stocks to Buy If the Market Crashes
Jun 14 / MotleyFool.com - Paid Partner Content